Oxford Immunotec Limited Schedules Fourth Quarter And Full Year 2013 Earnings Release And Conference Call For March 4, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 24, 2014 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) today announced that it plans to release fourth quarter and full year 2013 financial results prior to market open on Tuesday, March 4, 2014. Dr. Peter Wrighton-Smith, Chief Executive Officer and Rick Altieri, Chief Financial Officer will host a conference call to review the Company's results at 8:00am Eastern Time the same day. The call will be concurrently webcast.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC